Causes and Risk Factors for Osteosarcoma
Osteosarcoma is a rare but aggressive form of bone cancer that primarily affects children, adolescents, and young adults. Understanding the underlying mechanisms and predisposing factors is important for recognizing who may be at higher risk.
Key Takeaways
- Osteosarcoma develops when acquired changes in the DNA of bone-forming cells (osteoblasts) let them grow and divide without the normal controls.
- The most consistently identified risk factors are certain inherited genetic conditions and previous treatment with radiation or chemotherapy for another illness — not age or sex on their own.
- Inherited syndromes such as Li-Fraumeni syndrome, hereditary retinoblastoma, Rothmund-Thomson syndrome, Bloom syndrome, Werner syndrome, and Diamond-Blackfan anemia raise the risk, and genomic research has found inherited cancer-susceptibility gene variants in a meaningful minority of osteosarcoma patients.
- Radiation therapy given for an earlier cancer, especially at a young age, can raise the risk of osteosarcoma developing later in the treated bone.
- Most cases of osteosarcoma are sporadic, arising from DNA changes with no identifiable inherited or environmental cause, and there is currently no known way to prevent it through diet or lifestyle.
What Causes Osteosarcoma?
At its core, osteosarcoma develops when errors occur in the DNA of osteoblasts, the cells that build new bone. These changes disrupt the normal cycle of cell growth and division, letting abnormal cells multiply and form a tumor. The mutations themselves are the direct cause, but what triggers them in a given person is usually not known.
The process typically involves multiple genetic changes rather than a single event, often affecting genes that control cell growth, act as tumor suppressors, or repair DNA. When enough of these safeguards fail, cells can grow unchecked and form a malignant tumor within the bone.
The Role of DNA Mutations
Most osteosarcomas are sporadic — the DNA changes occur after birth and are not inherited from a parent. These acquired mutations can happen during normal cell division, though what triggers them is often impossible to pin down in an individual case. Two genes are involved especially often: TP53, a tumor suppressor gene, and RB1, the retinoblastoma gene. When these genes lose their normal function, cells can bypass the checkpoints that would otherwise stop damaged cells from dividing.
TP53 normally helps regulate cell growth and trigger the death of damaged cells; when it’s inactivated, cells with DNA damage can keep dividing and accumulate further mutations. RB1 normally helps control the cell cycle, and its loss lets cells divide without proper regulation. Genomic studies of osteosarcoma tumors find TP53 pathway changes in most cases and RB1 commonly inactivated as well, underscoring how central these two genes are to how the disease develops.
Key Risk Factors for Osteosarcoma
Not everyone who has one or more of the factors below goes on to develop osteosarcoma, and the disease also turns up in people with no identifiable risk factor at all. The factors most consistently identified for osteosarcoma fall into two categories: certain inherited genetic conditions, and previous treatment with radiation or chemotherapy for another illness.
These factors either contribute directly to the genetic changes that drive the disease or create conditions where such changes are more likely to occur or persist. The sections below cover each category, along with what’s known about the age pattern of diagnosis.
Age and Gender Demographics
Osteosarcoma is diagnosed most often during adolescence and young adulthood. Registry-based estimates put the incidence at roughly 5.4 cases per million people ages 0 to 19 each year in the United States, which works out to about 440 new cases annually in that age group. A smaller number of cases occur later in life, sometimes in a bone affected by Paget’s disease of bone or in an area that received radiation treatment years earlier for an unrelated condition.
Formal guidance on osteosarcoma risk factors does not list age or sex directly — it focuses on the genetic conditions and treatment history covered below. Whether biological sex affects the initial chance of developing osteosarcoma is less clearly established than its effect on outcomes after diagnosis, which is a topic covered on this cancer’s survival-rate page.
Genetic Predisposition to Osteosarcoma
Although most cases of osteosarcoma are sporadic, a meaningful share are linked to inherited genetic conditions. These involve germline variants — genetic changes present in every cell of the body from birth, which can be passed down through a family. Genomic research in large groups of people with osteosarcoma has found pathogenic or likely pathogenic inherited variants in cancer-susceptibility genes in a meaningful minority of them, and these variants were more frequent in children age 10 and younger.
The genes involved are typically ones that normally help suppress tumor growth. When they’re inherited in a non-working form, the body’s usual defenses against cancer are weakened. This is one reason a family history of early-onset cancer, or of one of the specific syndromes below, is a reason a doctor may suggest genetic counseling.
Inherited Syndromes and Risk
Several inherited conditions are associated with a higher chance of developing osteosarcoma. These include:
- Li-Fraumeni syndrome: caused by an inherited variant in the TP53 gene. Affected family members face a higher lifetime risk of several cancers, including bone tumors, soft tissue sarcomas, breast cancer, brain tumors, and leukemia. Among children and teens ages 6 to 19 with a TP53-related Li-Fraumeni variant, osteosarcoma is the most common type of sarcoma.
- Hereditary retinoblastoma: results from an inherited variant in the RB1 gene. Most people with hereditary retinoblastoma are diagnosed with this eye tumor by age 2 or 3, and those with the inherited form face a higher risk of later cancers, including osteosarcoma — particularly in bone that was previously treated with radiation for the retinoblastoma itself.
- Rothmund-Thomson syndrome: an inherited condition caused by mutations in the RECQL4 gene, associated with skin and hair changes, cataracts, short stature, and skeletal abnormalities; osteosarcoma tends to develop at a younger age in people with this syndrome.
- Bloom syndrome: caused by mutations in the BLM gene, this condition involves short stature and skin that reacts strongly to sunlight, along with a higher risk of several cancers, including osteosarcoma.
- Werner syndrome: causes signs of premature aging beginning in a person’s twenties — including graying hair, skin changes, and cataracts — and is linked to a higher risk of sarcomas, including osteosarcoma.
- Diamond-Blackfan anemia: an inherited disorder that limits the bone marrow’s ability to make red blood cells; it is also listed among the inherited conditions associated with osteosarcoma risk.
A family history of early-onset cancer, retinoblastoma, or any of these conditions is a reason to talk with a doctor about genetic counseling and what it might mean for screening.
Environmental Influences on Osteosarcoma Risk
Environmental risk factors for osteosarcoma are less common than sporadic mutations, but the clearest one is previous medical treatment for another condition. These exposures don’t cause osteosarcoma directly so much as raise the odds of it developing later on.
The best-documented environmental risk comes from earlier cancer treatment itself — a reminder that long-term monitoring is part of caring for anyone treated for cancer at a young age.
Radiation Exposure and Chemicals
Radiation therapy is the environmental factor most consistently linked to osteosarcoma. People who received radiation for another cancer — particularly at a young age or at high doses — have an increased chance of developing osteosarcoma in the treated area of bone, sometimes years after the original treatment. This pattern has been documented, for example, among some patients previously treated with radiation for retinoblastoma who later developed osteosarcoma in the radiation field.
Past chemotherapy is also included among the recognized risk factors, though it’s studied less than radiation. As with radiation, this risk is one of several possible long-term effects a care team weighs when planning cancer treatment for a child or young adult, set against the benefit of treating the original cancer. Other environmental exposures have been studied, but none is as clearly linked to osteosarcoma as prior radiation therapy.
Frequently Asked Questions
Is osteosarcoma hereditary?
Most cases of osteosarcoma are not inherited. But genomic research has found inherited variants in cancer-susceptibility genes in a meaningful minority of patients — conditions such as Li-Fraumeni syndrome and hereditary retinoblastoma are among those linked to a higher risk. A family history of these conditions, or of early-onset cancer generally, is a reason to consider genetic counseling.
Can diet or lifestyle choices prevent osteosarcoma?
No specific diet or lifestyle choice has been shown to prevent osteosarcoma, and it isn’t included among the recognized risk factors for this cancer. Most cases come from DNA changes that occur on their own, which is why there’s currently no established way to lower an individual’s risk through diet or exercise. A generally healthy lifestyle still supports overall health, just not specific protection against this particular cancer.
How common is osteosarcoma?
Osteosarcoma is rare overall. In people younger than 20, estimates put U.S. incidence at roughly 440 new cases a year, consistent with the age pattern described above. A fuller statistical picture, including rates across all age groups, is covered on this cancer’s statistics page.
Sources
